A 3-year-old child with Kawasaki disease in the acute phase has fever, bilateral conjunctival injection, strawberry tongue, polymorphous rash, and coronary artery aneurysms on echocardiogram. The parents are concerned about long-term complications. What is the most important nursing intervention to prevent thrombotic complications?
A 4-year-old child diagnosed with Kawasaki disease is hospitalized in the acute phase. The child has fever, bilateral conjunctival injection, strawberry tongue, and polymorphous rash. Echocardiogram reveals coronary artery aneurysms. The parents express anxiety about their child's condition and ask about preventing complications.
1Administer low-dose aspirin as prescribed and monitor for bleeding complications✓ 정답
2Encourage increased fluid intake to maintain adequate hydration
3Apply cool compresses to reduce fever and inflammation
4Restrict physical activity to complete bed rest
해설
Low-dose aspirin is essential to prevent thrombotic complications in Kawasaki disease with coronary aneurysms by inhibiting platelet aggregation. Other options are supportive but do not directly address the primary risk of clot formation.
Understanding the Pathophysiology
Kawasaki disease (KD) is an acute, self-limited medium-vessel vasculitis that primarily affects young children. The most serious complication is the development of coronary artery abnormalities (CAAs), including aneurysms. In the acute phase, intense inflammation of the vessel wall leads to endothelial injury. When an aneurysm forms, the damaged endothelium and the abnormal, turbulent blood flow within the dilated segment create the perfect conditions for platelet activation and adhesion, a process now understood as thrombo-inflammation[1]. This significantly elevates the risk of thrombus formation within the aneurysm, which can lead to myocardial infarction or sudden death. Therefore, while controlling inflammation with intravenous immunoglobulin (IVIG) is the primary acute-phase goal, preventing thrombosis in a child with established aneurysms becomes a critical, parallel nursing priority [1].
Analysis of the Correct Answer (Option 1)
Administering low-dose aspirin as prescribed and monitoring for bleeding complications is the most important nursing intervention. The rationale is directly tied to the pathophysiology of thrombo-inflammation. High-dose aspirin (80-100 mg/kg/day) is used initially for its anti-inflammatory effects during the acute febrile phase. Once the fever subsides, the dose is reduced to an antiplatelet dose (3-5 mg/kg/day) to specifically target platelet aggregation and prevent thrombus formation in the damaged coronary arteries [1,4]. For a child with confirmed coronary artery aneurysms, this antiplatelet therapy is the cornerstone of long-term thrombotic prevention. The nursing responsibility extends beyond administration to vigilant monitoring for signs of aspirin toxicity and bleeding, such as bruising, petechiae, or gastrointestinal bleeding, making this option the most comprehensive and directly preventative intervention.
Analysis of Incorrect Answers
- Option 2: Encouraging increased fluid intake is a supportive measure for any febrile child to maintain hydration and comfort. While important for overall care, it does not directly address the specific, life-threatening pathophysiological process of thrombus formation within a coronary artery aneurysm. It is a general intervention, not the priority for preventing thrombotic complications.
- Option 3: Applying cool compresses is a comfort measure to manage fever and skin inflammation. Like hydration, it addresses symptoms of the acute inflammatory process but has no direct impact on platelet aggregation or the prevention of thrombosis in the coronary arteries. It is a low-priority intervention in the context of this specific complication.
- Option 4: Restricting physical activity to complete bed rest is not a standard recommendation for KD. While activity may be limited during the acute febrile phase due to the child's malaise, prolonged strict bed rest is unnecessary and can be detrimental to the child's developmental and psychosocial well-being. The primary prevention of thrombosis is pharmacological, not through activity restriction.
Clinical Application and Evidence
The standard of care for KD with coronary artery aneurysms is antiplatelet therapy with low-dose aspirin . The concept of thrombo-inflammation highlights that inflammation and coagulation are linked processes in KD vasculitis, making antiplatelet agents essential [1]. For children who develop giant coronary artery aneurysms (GCAAs, typically defined as a z-score ≥ 10 or an absolute internal diameter ≥ 8 mm), the thrombotic risk is so high that dual therapy with an anticoagulant, such as warfarin or a direct oral anticoagulant (DOAC) like rivaroxaban, is often added to aspirin [2,3]. A systematic review and meta-analysis found that DOACs may offer a comparable safety and efficacy profile to conventional anticoagulation in children with KD-associated GCAAs, though aspirin remains the foundational therapy . A prospective cohort study on rivaroxaban for thromboprophylaxis in children with acquired heart disease, including KD, further supports the use of anticoagulation in high-risk groups, but always in addition to, not replacing, antiplatelet therapy . Your nursing assessment must include a careful history and physical exam focused on signs of bleeding, patient and family education on the critical importance of medication adherence, and the need for regular follow-up echocardiograms to monitor aneurysm progression.
References (research sources)
[1]
Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease.Research articleKocatürk B, Berberoğulları B, Aliyev E, Sağ E, Özen S, Arditi M. (2026) · DOI: 10.1007/s11926-026-01211-5
Clinical Practice Guide: Antiplatelet Management in Kawasaki Disease with Coronary Aneurysms
Risk Stratification
Echocardiographic findings dictate thromboprophylaxis intensity. Small aneurysms (Z-score 2.5 to <5) require low-dose aspirin alone. Medium aneurysms (Z-score 5 to <10, or absolute dimension 4-8 mm) typically warrant dual antiplatelet therapy with aspirin and a P2Y12 inhibitor (e.g., clopidogrel). Giant aneurysms (Z-score ≥10 or absolute dimension >8 mm) require dual antiplatelet therapy plus systemic anticoagulation (warfarin or low molecular weight heparin) due to the highest thrombotic risk.
Aspirin Dosing Protocol
During the acute febrile phase, high-dose aspirin (80-100 mg/kg/day divided every 6 hours) is used for its anti-inflammatory effect. Once the child is afebrile for 48-72 hours, the dose is reduced to antiplatelet dosing (3-5 mg/kg/day once daily). This low-dose regimen continues indefinitely for patients with persistent coronary aneurysms. Discontinuation is considered only if aneurysms fully regress and no stenosis develops.
Nursing Monitoring Priorities
Assess for signs of bleeding: epistaxis, gingival bleeding, easy bruising, petechiae, prolonged bleeding from minor cuts, or dark/tarry stools. Monitor hemoglobin and hematocrit periodically. Educate parents to use a soft-bristled toothbrush, avoid NSAIDs unless specifically prescribed, and report any head trauma immediately due to intracranial hemorrhage risk. For children on warfarin, ensure consistent vitamin K intake and regular INR monitoring.
Activity and Lifestyle Guidance
Complete bed rest is not recommended. Children should engage in age-appropriate activities. For those on antiplatelet therapy alone, no restrictions are needed beyond standard safety precautions. For those on anticoagulation, avoid contact sports, climbing activities with fall risk, and activities involving sharp objects. Always ensure the child wears a properly fitted helmet when cycling or participating in wheeled activities.
Parent Education Essentials
Explain that the aneurysm wall is damaged and prone to clot formation; aspirin makes platelets less "sticky" to prevent this. Emphasize never to stop aspirin abruptly without cardiology consultation. Discuss the importance of annual cardiology follow-up with echocardiography and ECG, and potentially stress testing in adolescence. Provide a medical alert bracelet indicating antiplatelet/anticoagulant use. Discuss the risk of Reye syndrome: avoid aspirin if the child develops varicella or influenza-like illness and seek immediate medical guidance.
Kawasaki disease — An acute, self-limited medium-vessel vasculitis primarily affecting young children, with coronary artery aneurysms as the most serious complication.
Coronary artery aneurysm — An abnormal dilation of a coronary artery segment resulting from vessel wall inflammation, creating turbulent flow and a high risk for thrombosis.
Thrombo-inflammation — The interplay between inflammation and thrombosis, where endothelial injury and platelet activation mutually amplify each other, especially relevant in vasculitis.
Low-dose aspirin — An antiplatelet dose (3-5 mg/kg/day) used after the acute febrile phase of Kawasaki disease to inhibit platelet aggregation and prevent thrombus formation.
Antiplatelet therapy — Pharmacologic intervention to prevent platelet adhesion and aggregation, reducing the risk of arterial thrombotic events in conditions like coronary aneurysms.